Biochemist synthesizes ChatGPT-designed schizophrenia drug in garage lab

Biochemist Douglas Yao showcased PAC-3310, an experimental schizophrenia drug designed with ChatGPT, which he synthesized in his garage lab and claims showed antipsychotic effects in mice.

2026-09-09 ~ 2026-09-10 · 4 related posts

• Developer synthesizes PAC-3310, a ChatGPT-designed schizophrenia drug candidate, in his garage — CatAstro_Piyush · 2026-09-09
• "Vibe-chemist" uses ChatGPT to design and synthesize an experimental schizophrenia drug in his garage — Polymarket · 2026-09-09
• User claims he synthesized PAC-3310, a ChatGPT-designed schizophrenia drug, in his garage lab — SatelliteNetSec · 2026-09-09
• Biochemist says ChatGPT-designed schizophrenia drug was synthesized in his garage — examachine · 2026-09-10